ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter

Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as against Rs 94.86 crore during the previous quarter ended June 2023. Sales rose 55.55% to Rs 715.59 crore in the quarter ended June 2024 as against Rs 460.03 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	715.59	460.03	56
OPM %	34.93	36.90	-
PBDT	191.26	153.38	25
PBT	115.32	112.49	3
NP	83.18	94.86	-12